Rearrangement of the Mixed Lineage Leukemia (MLL, or KMT2A) gene is a cytogenetic aberration highly prevalent in infants (<1 year of age) diagnosed with acute lymphoblastic leukemia (ALL), where it constitutes ∼80% of the cases. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.